Helen Torley sold $6.3M of HALO stock

Helen Torley, President And CEO of Halozyme Therapeutics, Inc. (HALO), sold 60,000 shares of HALO stock worth $6.3M, per an SEC Form 4 filed Aug 20, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Aug 17, 2026, 3 days before it was made public.

HALO has moved -1.3% since the trade date, from $103.00 to $101.68 (Nov 11, 2026 close).